couter

Oct 15, 2026 — Strategic Review & Balance Sheet Update
Chart by TradingView

The schedule

  • Thu15Oct

    Interim update on asset divestitures or a potential capital raise to address the $690M debt burden.

  • Tue12Jan

    Presentations at the JPM Healthcare Conference detailing FY27 guidance and turnaround strategy.

  • Thu25Feb

    Q3 2026 earnings release focusing on bioprinting placements and pharma capex budgets under high interest rates.

  • Thu25Feb

    Q4 and full-year 2026 financial results, finalizing the impact of annual cost-cutting measures.

  • Thu27May
  • Thu26Aug

    Q1 2027 earnings release, providing an early gauge of fiscal 2027 revenue momentum and liquidity.

Past

  • Thu27Aug

    BICO Group's upcoming Q2 2026 earnings release, evaluating cash flow sustainability amidst structural revenue contraction.